972 related articles for article (PubMed ID: 12449891)
1. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP
Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891
[TBL] [Abstract][Full Text] [Related]
2. Antileprosy protective vaccination of sooty mangabey monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):434-43. PubMed ID: 11332286
[TBL] [Abstract][Full Text] [Related]
3. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
[TBL] [Abstract][Full Text] [Related]
4. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
[TBL] [Abstract][Full Text] [Related]
5. Pilot study to determine acceptability and ability of heat-killed Mycobacterium leprae plus BCG (HKML+BCG) vaccine to induce skin test conversion.
Chen ZL; Tang QG; Wang ZM; Chen J
Lepr Rev; 1993 Jun; 64(2):117-27. PubMed ID: 8341114
[TBL] [Abstract][Full Text] [Related]
6. Vaccination of human volunteers with heat-killed M. leprae: local responses in relation to the interpretation of the lepromin reaction.
Gill HK; Mustafa AS; Godal T
Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):36-44. PubMed ID: 3286799
[TBL] [Abstract][Full Text] [Related]
7. Protective immunization of monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: clinical results.
Gormus BJ; Baskin GB; Xu K; Bohm RP; Mack PA; Ratterree MS; Cho SN; Meyers WM; Walsh GP
Lepr Rev; 1998 Mar; 69(1):6-23. PubMed ID: 9628092
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
[TBL] [Abstract][Full Text] [Related]
9. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
Chaudhury S; Hazra SK; Saha B; Mazumder B; Biswas PC; Chattopadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
[TBL] [Abstract][Full Text] [Related]
10. Immunological changes observed in indeterminate and lepromatous leprosy patients and Mitsuda-negative contacts after the inoculation of a mixture of Mycobacterium leprae and BCG.
Convit J; Aranzazu N; Pinardi M; Ulrich M
Clin Exp Immunol; 1979 May; 36(2):214-20. PubMed ID: 383331
[TBL] [Abstract][Full Text] [Related]
11. Fernandez and Mitsuda reactivity in guinea pigs sensitized with heat-killed Mycobacterium leprae: persistence and specificity of skin reactivity to soluble and particulate antigens.
Collins FM; Morrison NE; Watson SR
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):481-9. PubMed ID: 6423556
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
[TBL] [Abstract][Full Text] [Related]
13. Armadillos (Dasypus novemcinctus) as a model to test antileprosy vaccines; a preliminary report.
Job CK; Sanchez RM; Hunt R; Truman RW; Hastings RC
Int J Lepr Other Mycobact Dis; 1993 Sep; 61(3):394-7. PubMed ID: 8228437
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy with a mixture of Mycobacterium leprae and BCG in different forms of leprosy and in Mitsuda-negative contacts.
Convit J; Aranzazu N; Ulrich M; Pinardi ME; Reyes O; Alvarado J
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):415-24. PubMed ID: 6763002
[TBL] [Abstract][Full Text] [Related]
15. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
Gupte MD; Vallishayee RS; De Britto LJ; Anantharaman DS
Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
[TBL] [Abstract][Full Text] [Related]
16. Vaccination and skin test studies on children living in villages with differing endemicity for leprosy and tuberculosis.
Ghazi Saidi K; Stanford JL; Stanford CA; Dowlati Y; Farshchi Y; Rook GA; Rees RJ
Int J Lepr Other Mycobact Dis; 1989 Mar; 57(1):45-53. PubMed ID: 2659701
[TBL] [Abstract][Full Text] [Related]
17. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.
Gormus BJ; Meyers WM
Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362
[TBL] [Abstract][Full Text] [Related]
18. Sensitization studies with potential leprosy vaccine preparations in northern Malawi.
Ponnighaus JM; Fine PE
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):25-37. PubMed ID: 3519803
[TBL] [Abstract][Full Text] [Related]
19. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
De Britto RL; Ramanathan VD; Gupte MD
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
[TBL] [Abstract][Full Text] [Related]
20. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
